drugset
drugset / Trial / NCT04782388

Study to Assess the Safety, Tolerability, And Pharmacokinetics of Staccato Alprazolam in Healthy Japanese, Chinese, and Caucasian Participants

NCT04782388 ↗

Phase 1 Completed 30 enrolled UCB Biopharma SRL
RandomizedParallel-groupQuadruple-blindBasic science

Summary

The purpose of the study is to assess the safety, tolerability, and pharmacokinetics (PK) of Staccato alprazolam in healthy Japanese, Chinese, and Caucasian participants.

Timeline

Start
2021-03-04
Primary completion
2021-04-26
Completion
2021-04-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Alprazolam Small molecule — —

Indications

No indication recorded.